BUSINESS ALIGNMENT PUBLIC COMPANY LIMITEDSET: BIZ🇹🇭 TH

MD&A · 2025

Overview of Operations

Overview of Operations

Business Alignment Company Limited ("the Company") engages in the distribution and installation of medical equipment for cancer treatment using radiotherapy. The products are imported from manufacturers specialized in equipment and technology for cancer treatment, known for their expertise and being among the leading providers globally. Additionally, the Company provides maintenance services for such medical equipment. The main customer groups include medical school-affiliated hospitals, cancer hospitals under the Ministry of Public Health, other government hospitals, healthcare agencies, and private hospitals.

The majority of the Company's revenue comes from selling products in project-based contracts. As a Solution Provider, the Company takes responsibility for various aspects, starting from structural work to systems such as electrical systems, cooling systems, and interior design, to prepare the facilities for installing radiation machines and other equipment. Afterward, the Company handles procurement, installation, and maintenance of various equipment related to radiation therapy, such as radiation machines, treatment planning systems, and other necessary accessories, ensuring that the products ordered by customers are operational.

The nature of the business results in the recognition of revenue from sales when projects are delivered. This means that the Company must undertake construction of radiation rooms, procure and install various equipment, and undergo acceptance inspection by the customer’s Inspection Committee to recognize the revenue. The duration of work for each project ranges from 210 to 360 days. This is a factor that exposes the Company to the risk of revenue uncertainty and discontinuity if it fails to deliver the work within the planned accounting periods.

Debt Securities with Financial Ratio Requirements

Debt Securities with Financial Ratio Requirements Issued?

No

Factors That May Affect Financial Condition

Factors or Incidents That May Materially Affect Financial Condition

Due to the nature of the business and the unique characteristics of the Company's products, both in terms of technology and business model as previously mentioned, the Company have factors that might affect its operational performance as follows:

  1. Standard accounting practice states that the Company must recognize its revenue only when it has completely transferred the risks associated with the product to the customer. For high-value project works, which typically take 210-360 days (from the date of the sale contract) to complete and deliver to the customer, the entire revenue can be recognized upon project completion and delivery. Therefore, if the Company fails to deliver the project within the planned accounting period, and if the delayed project is a high-value one, the Company faces the risk of revenue discontinuity in each accounting period because it has to defer revenue recognition to the next accounting period.

  2. With specialty products having an average lifespan of about 12-15 years, coupled with the potential for lengthy development and testing periods for radiation therapy technology changes, it has led to a unique market condition for the Company's business. Specifically, the Company's customer base tends to be niche-focused, primarily serving customers in the healthcare sector. This limits the market demand and requirements for the Company's products to these specialized customer groups, or it may be constrained by the relatively long lead times for ordering new products to replace old ones. Therefore, these factors pose a risk to the Company's long-term revenue expansion capabilities, as they may lead to revenue discontinuity and uncertainty in the future.

  3. The interest rate risk, which may arise from future changes in interest rates in the market, could affect the Company due to its borrowings from financial institutions. However, the majority of the Company's financial assets and liabilities have interest rates that are either adjusted according to market rates or have fixed interest rates closely aligned with current market rates. Therefore, the interest rate risk for the Company is considered low.

  4. The credit risk arises from the possibility that the trading counterparties may not be able or willing to fulfill the agreements made. However, the Company does not have significant credit risk exposure as it regularly assesses the financial status of its debtors. Additionally, the majority of the Company's trade debtors are government entities, further reducing the credit risk.

  5. The foreign exchange risk arises from the Company's purchases of goods and expenses incurred in foreign currencies, particularly for products imported for high-value projects. However, the Company manages this risk by entering into forward contracts for foreign currency transactions in advance. Consequently, the risk stemming from exchange rate fluctuations is minimal.

  6. The liquidity risk is monitored by the Group through tracking the risk of illiquidity resulting from borrowing from financial institutions and lease agreements. The Group has assessed the vulnerability associated with borrowing money to repay existing debts and concluded that the risk is low. Additionally, the Group has sufficient access to diverse sources of capital.

However, according to projections from the World Health Organization (WHO), the trend suggests an increase in cancer patients in Thailand. Currently, Thailand lacks radiotherapy machines. Consequently, the Company anticipates continuous demand for its products from its target customer groups. Allocating budget to meet the needs of both public and private hospitals for purchasing the Company’s products to meet current and future patient needs is seen as necessary. This presents an opportunity for affiliated institutions to consider investing in the Company's products.

Contents